Ipsen is a global biopharmaceutical company dedicated to improving lives through innovative medicines in Oncology, Neuroscience and Rare Diseases. In Rare Diseases, Ipsen is committed to making high-quality, innovative therapeutic treatments available to people with rare diseases and supporting them and their families with medicines, services and solutions across the entire continuum of care, from diagnosis to treatment follow-up. Its goal is to leave no patient behind. Ipsen has a global presence and capabilities to serve patients around the world: with medicines available in 120 countries and a direct commercial presence in more than 30 countries.
For more information on Ipsen, visit www.ipsen.com